With protoescigenin as starting material and through orchestrated application of Yu and Schmidt glyco-sylation protocols, the synthesis of acyl group-free escin derivatives were achieved for the first time.As the undesired non-specific toxicity, originated from the existence of acyl groups on aglycone, prohibits the wide application of escins, the established strategies toward nonacylated protoescigenin-type sap-onins would dramatically ease the access to escin derivatives dispense of acyl groups, thereby speeding up the pace of pharmaceutical use of these valuable compounds.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: